Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M85.6Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-12.3
Enterprise Value $M79.2EPS (TTM) $-0.7Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book12410-y EBITDA Growth Rate %-3.5Quick Ratio3.2Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-1.0Current Ratio3.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-112.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-212.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M34.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with GALT

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

GALT is held by these investors:



GALT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ZUCCONI THEODORE DANIELDirector 2017-05-23Buy1,000$2.278.81view
CZIRR JAMES CDirector 2016-04-20Sell44,312$1.6747.9view
10X Fund, L.P.10% Owner 2016-04-20Sell44,312$1.6747.9view
10X Fund, L.P.10% Owner 2016-04-20Sell44,312$1.6549.7view
CZIRR JAMES CDirector 2016-04-20Sell44,312$1.6549.7view
Greenberg ArthurDirector 2016-01-05Buy1,666$1.7243.6view
AMELIO GILBERT FDirector 2015-11-30Sell100$2.117.62view
TRABER PETER GPresident & CEO 2015-08-12Buy2,000$223.5view
TRABER PETER GPresident & CEO 2015-06-01Buy4,000$2.53-2.37view
FREEMAN KEVIN DDirector 2015-06-01Buy2,083$2.7-8.52view

Press Releases about GALT :

Quarterly/Annual Reports about GALT:

News about GALT:

Articles On GuruFocus.com
Patent for Reducing Inflammatory Response Granted to Galectin Therapeutics Jun 21 2017 
Autoimmune Disease Patent Granted to Galectin Therapeutics Jun 06 2017 
Galectin Therapeutics Reports 2017 First Quarter Financial Results and Provides Business Update May 15 2017 
Charles Brandes Invests in Health Care in 1st Quarter May 11 2017 
Galectin Therapeutics launches the Liver Line, an online community and publication on liver health a May 03 2017 
Galectin Therapeutics Receives Notice of Japanese Decision to Grant a Composition of Matter Patent f Apr 25 2017 
Galectin Therapeutics and Exalenz to Present Late-Breaking Abstract at The International Liver Congr Apr 18 2017 
Galectin Therapeutics Reports 2016 Financial Results and Provides Business Update Mar 28 2017 
Galectin Therapeutics Issues Statement Regarding GALTW and GALTU Mar 23 2017 
Galectin Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Busin Mar 21 2017 

More From Other Websites
[$$] Drug Companies Seek to Raise Awareness of Liver Ailment Jun 23 2017
Patent for Reducing Inflammatory Response Granted to Galectin Therapeutics Jun 21 2017
Galectin Therapeutics Announces Important Milestones towards Completion of NASH CX Trial Jun 13 2017
Autoimmune Disease Patent Granted to Galectin Therapeutics Jun 06 2017
Galectin Therapeutics Reports 2017 First Quarter Financial Results and Provides Business Update May 15 2017
Galectin Therapeutics launches the Liver Line, an online community and publication on liver health... May 03 2017
Can The Uptrend Continue for Galectin Therapeutics (GALT)? Apr 28 2017
Galectin Therapeutics Receives Notice of Japanese Decision to Grant a Composition of Matter Patent... Apr 25 2017
Will Henry Schein (HSIC) Deliver a Surprise in Q1 Earnings? Apr 24 2017
Can Myriad Genetics (MYGN) Spring a Surprise in Q3 Earnings? Apr 24 2017
Edward Lifesciences (EW) Q1 Earnings: A Surprise in Store? Apr 20 2017
Can Mead Johnson (MJN) Spring a Surprise in Q1 Earnings? Apr 20 2017
ResMed (RMD) Q3 Earnings: Disappointment in the Cards? Apr 18 2017
IDEXX Laboratories (IDXX) Q1 Earnings: Surprise in Store? Apr 18 2017
Galectin Therapeutics and Exalenz to Present Late-Breaking Abstract at The International Liver... Apr 18 2017
Can Illumina (ILMN) Spring a Surprise this Earnings Season? Apr 17 2017
5 Drug Stocks That Could Be Big Winners this Earnings Season Apr 17 2017
Integra LifeSciences (IART) Q1 Earnings: A Beat in Store? Apr 13 2017
GNC Holdings (GNC) Q1 Earnings: Disappointment in Store? Apr 12 2017
Galectin Therapeutics and Axovant Sciences See Stocks Rise on Investor Optimism Apr 11 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}